Member Exclusive
First patient dosed in Japanese iPSC Parkinson’s trial
A patient in his 50s received iPSC-derived nerve cells to supplement dopamine-emitting neurons.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
- Connect and collaborate with other members
- Post about your own research, share your take on key topics and more
No comments yet.